Transurethral resection of the prostate (TURP) is a medical procedure that may help treat benign prostatic hyperplasia (BPH). Medicare covers TURP for people who meet their requirements. Yes, Medicare ...
CorePlus and Ibex have deployed Ibex Prostate for TURP within a Lab Developed Test (LDT) workflow for enhanced diagnostic ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
The US Food and Drug Administration (FDA) has cleared Prodeon Medical’s implantable technology for treating lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The ...
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
Benign prostatic hyperplasia (BPH) is extremely common in the aging man and may cause significant lower urinary tract symptoms (LUTS) necessitating treatment. Drug treatment is the mainstay of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results